These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23478912)

  • 1. Vaccine and immunotherapeutic interventions.
    Pantaleo G; Lévy Y
    Curr Opin HIV AIDS; 2013 May; 8(3):236-42. PubMed ID: 23478912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Immune Interventions for an HIV-1 Cure.
    Perreau M; Banga R; Pantaleo G
    Trends Mol Med; 2017 Oct; 23(10):945-961. PubMed ID: 28890135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune interventions in HIV infection.
    Carcelain G; Autran B
    Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
    Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
    Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy as an adjunct to highly-active antiretroviral therapy.
    Murphey-Corb M; Heydenburg-Fuller D
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1191-7. PubMed ID: 11717803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy and therapeutic vaccines in HIV infection.
    García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic vaccines against HIV infection.
    García F; León A; Gatell JM; Plana M; Gallart T
    Hum Vaccin Immunother; 2012 May; 8(5):569-81. PubMed ID: 22634436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change.
    Pantaleo G; Levy Y
    Curr Opin HIV AIDS; 2016 Nov; 11(6):576-584. PubMed ID: 27607591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic vaccination against HIV: current progress and future possibilities.
    Puls RL; Emery S
    Clin Sci (Lond); 2006 Jan; 110(1):59-71. PubMed ID: 16336205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution in HIV-1-infected patients.
    Imami N; Hardy G; Pires A; Burton C; Pido-Lopez J; Mela C; Gotch F
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1138-45. PubMed ID: 12211404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Various approaches of therapeutic vaccination for the treatment of HIV type 1 infection].
    Lazrek M; Lobert PE; Goffard A; Schanen C; Dewilde A; Bocket L; Hober D
    Ann Biol Clin (Paris); 2005; 63(6):581-8. PubMed ID: 16330376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of HIV-1 latent reservoirs through therapeutic vaccination.
    Pankrac J; Klein K; Mann JFS
    AIDS Res Ther; 2017 Sep; 14(1):45. PubMed ID: 28893280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune control of HIV-1 reservoirs.
    Autran B; Descours B; Bacchus C
    Curr Opin HIV AIDS; 2013 May; 8(3):204-10. PubMed ID: 23493099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding HIV infection for the design of a therapeutic vaccine. Part II: Vaccination strategies for HIV.
    de Goede AL; Vulto AG; Osterhaus AD; Gruters RA
    Ann Pharm Fr; 2015 May; 73(3):169-79. PubMed ID: 25528627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.
    García F; Climent N; Guardo AC; Gil C; León A; Autran B; Lifson JD; Martínez-Picado J; Dalmau J; Clotet B; Gatell JM; Plana M; Gallart T;
    Sci Transl Med; 2013 Jan; 5(166):166ra2. PubMed ID: 23283367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.
    Angel JB; Routy JP; Tremblay C; Ayers D; Woods R; Singer J; Bernard N; Kovacs C; Smaill F; Gurunathan S; Sekaly RP
    AIDS; 2011 Mar; 25(6):731-9. PubMed ID: 21330911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy of HIV infection].
    Harrer T
    Wien Med Wochenschr; 1998; 148(23-24):560-6. PubMed ID: 10189687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.